Balchem BCPC Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| Animal Nutrition and Health | $230.85M+7.5% | $214.71M-9.9% | $238.33M-9.1% | $262.3M+15.7% | |
| Human Nutrition and Health | $659.39M+9.9% | $600.26M+9.0% | $550.75M+4.5% | $527.13M+19.1% | |
| Specialty Products | $140.98M+6.2% | $132.75M+5.4% | $125.97M-4.2% | $131.44M+12.3% | |
| Net Sales by Product | |||||
| Product Sales Revenue | $1.04B+8.8% | $951.95M+3.5% | $919.95M-2.0% | $939.17M+18.2% | |
| Royalty Revenue | $1.89M+8.8% | $1.74M-30.2% | $2.49M-22.1% | $3.19M-29.1% | |
| Net Sales by Geography | |||||
| Non-US | $277.71M+20.5% | $230.38M-1.1% | $232.84M-10.5% | $260.12M+21.3% | |
| United States | $759.45M+5.0% | $723.3M+4.9% | $689.6M+1.1% | $682.24M+16.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Balchem break its business down?
- Balchem (BCPC) reports net sales by business across 3 parts — Animal Nutrition and Health, Human Nutrition and Health and Specialty Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Balchem's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Balchem's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
